Daré Bioscience Presents DARE-IDDS Drug Delivery Device at PODD Conference

• Daré Bioscience will showcase its investigational DARE-IDDS drug-delivery device at the Partnership Opportunities in Drug Delivery conference, October 29-30, 2026, in Boston.
• Liz Proos, vice president of product development, will present October 30 from 2:30 to 2:50 p.m. ET.
• The implantable device is designed to deliver more than 100 programmable doses over months to years, with wireless treatment monitoring and adjustment.
• Initially targeting contraception, the platform remains in preclinical development.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dare Bioscience Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610260832PRIMZONEFULLFEED9852293) on October 26, 2026, and is solely responsible for the information contained therein.